与癌症相关的G 蛋白偶联受体及通路的研究进展

G蛋白偶联受体(G protein-coupled receptors,GPCRs)是一类重要的细胞膜表面跨膜蛋白受体超家族,具有7个跨膜螺旋结构。GPCRs的细胞内信号由G蛋白介导,可将激素、神经递质、药物、趋化因子等多种物理和化学的细胞外刺激穿过细胞膜转导到细胞内不同的效应分子,激活相应的信号级联系统进而影响恶性肿瘤的生长迁移过程。虽然目前药物市场上有很多治疗癌症的小分子药物属于G蛋白受体相关药物,但所作用的靶点集中于少数特定G蛋白偶联受体。因此,新的具有成药性的G蛋白偶联受体的开发具有很大的研究价值和市场潜力。本文主要以在癌症发生、发展中起重要作用的溶血磷脂酸(LPA),G蛋白偶联受体30(GPR30)、内皮素A受体(ETAR)等不同G蛋白偶联受体为分类依据,综述其与相关的信号通路在癌症进程中的作用,并对相应的小分子药物的临床应用和研究进展进行展望。     

G蛋白偶联受体相关分选蛋白功能特征与相关疾病研究进展

G蛋白偶联受体(G protein-coupled receptors,GPCRs)作为最大的一类膜蛋白受体家族,可被多种配体激活并发挥相应的信号转导功能,参与生物体内重要的生理过程.G蛋白偶联受体相关分选蛋白(G protein-coupled receptors associated sorting protein...     

甘丙肽受体的研究进展

目前已经克隆了3种甘丙肽受体（GalR1, GalR2, GalR3）,它们都是与G蛋白相偶联的受体.3种甘丙肽受体的氨基酸序列、药理学特性以及第二信使系统各不相同.GalR1/3受体可以抑制腺苷酸环化酶并可以激活钾通道,GalR2受体可以激活磷脂酶C并增加胞内钙离子浓度.用RNA印迹、反转录PCR以及原位杂交等技术对上述3种甘丙肽受体在人、大鼠和小鼠中的分布进行了研究,发现它们具有不同的分布特征,提示不同的甘丙肽受体可能参与不同的生理过程.     

G蛋白偶联受体介导游离脂肪酸的信号通路及生理功能

游离脂肪酸（free fatty acid,FFA）是动物一种重要能量来源,同时它还是一种重要的信号分子,其生理功能和作用机制长期以来倍受关注. 最近研究表明,细胞膜存在FFA的特定孤儿型G蛋白偶联膜受体家族.中长链游离脂肪酸是GPR40和GPR120的配基,而短链游离脂肪酸则是GPR41和GPR43的配基. 该受体家族可以介导游离脂肪酸,通过ERK、PI3K-Akt和MAPK信号通路,在维持机体内的葡萄糖稳态、脂肪形成、白细胞功能和细胞增殖等生理过程中发挥重要作用. 本文就游离脂肪酸G蛋白偶联受体的结构、分布、配体选择性、下游信号通路,及其介导FFA生理功能的最新研究进展进行简要综述.     

与阿尔兹海默症相关的G 蛋白偶联受体研究进展

G蛋白偶联受体(GPCRs)在大脑信号传递中至关重要,而在阿尔兹海默症(AD)中,G蛋白偶联受体通过调控α-、β-及γ-分泌酶分泌、淀粉样前体蛋白(APP)生成及β-淀粉样蛋白(Aβ)降解,直接影响β-淀粉样蛋白在神经系统信号级联反应;另外,阿尔兹海默症中β-淀粉样蛋白的生成可以扰乱G蛋白偶联受体功能.因此,阐明G蛋白偶联受体与阿尔兹海默症发病之间的关联有助于开发以G蛋白偶联受体为靶点的阿尔兹海默症治疗药物.     

鲜味受体研究进展

味觉对于生命具有重要作用,在一定程度上确定了人类对事物的选择。味觉由甜、咸、苦、酸和鲜等5种基本味道组成,味觉的感知是通过存在于舌上味觉表面的特异性受体来实现的,大多数味觉受体都属于G蛋白偶联受体家族。近几年的研究揭示了感知鲜味的2类这样的受体,鲜觉受体的阐明使人们对味觉的理解有了较为全面的认识。     

G蛋白偶联受体介导的神经信号跨膜转导

Ｇ蛋白偶联受体介导的神经信号跨膜转导郭君,周安武,杜雨苍（中国科学院上海生物化学研究所,上海２０００３１）关键词Ｇ蛋白偶联受体,神经信号跨膜转导受体是细胞膜或细胞内的一些首先能与生物活性物质相互作用的分子,它们能够识别配基并与其结合,然后将受体与配基...     

植物病原丝状真菌G蛋白偶联受体的研究进展

通过对丝状真菌G蛋白偶联受体(GPCR)的结构、分类以及功能方面进行综述,以期明确丝状真菌与其他模式生物GPCR之间的关系。基于已报道的模式生物及丝状真菌等不同生物中的GPCR,通过SMART保守结构域分析,以及利用Clustal X、MEGA等软件对上述GPCR进行遗传关系分析。明确丝状真菌典型GPCR具有七跨膜结构域,新型GPCR则含有PIPK、RGS等保守结构域,明确不同学者对于GPCR的分类情况,以及新型GPCR所具有的特殊功能,明确模式生物GPCR、丝状真菌GPCR分别各自聚类。丝状真菌中GPCR的数量较模式生物少,不同分类单元中真菌之间GPCR的数量也不尽相同,同时,丝状真菌GPCR除具有典型的七跨膜结构域外,还含有一些其他保守的结构域,上述研究为进一步开展其功能研究提供重要的理论基础。     

mGluR 1／5介导的下游信号通路

代谢型谷氨酸受体l／5（mGluR1／5）是G蛋白偶联受体家族C的重要成员之一,该受体及其介导的下游信号在调节神经系统的正常生理功能起着非常重要作用,并与相关神经系统退行性疾病密切相关。文章介绍了mGluR1／5所介导的信号通路、信号通路调控的分子机制以及其他GPCR受体的相互作用对信号共同调节的分子机制等方面最新研究进展。     

G蛋白偶联受体二聚化研究进展

G蛋白偶联受体是细胞膜受体最大的家族,参与调节多种生理过程,在信号识别及转导中具有重要作用,传统观点认为G蛋白偶联受体作为单体起作用,近年来,越来越多的证据表明,G蛋白偶联受体不仅能以二聚体形式存在,而且在细胞信号转导中起重要作用,尤其是对阿片受体异源二聚体的研究,推动了这一领域的研究。本文综述了G蛋白偶联受体二聚化研究进展,以及同源和异源二聚体的结构与功能。     

G蛋白偶联受体激酶的调控

G蛋白偶联受体激酶(G protein-coupled receptor kinase,GRK)特异地使活化的G蛋白偶联受体(G protein-coupled receptor,GPCR)发生磷酸化及脱敏化,从而终止后者介导的信号转导通路。研究表明,GRK的功能被高度调控,并具有下行调节GPCR的能力。调控GRK功能的机制包括两个层次：(1)多种途径调控激酶的亚细胞定位及活性,包括GPCR介导、G蛋白偶联、磷脂作用、Ca^2 结合蛋白调控、蛋白激酶C活化、MAPK反馈抑制、小窝蛋白抑制等;(2)调控GRK表达水平,主要体现在其与某些疾病的联系。     

Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy

Parathyroid hormone (PTH) is an important regulator of osteoblast function and is the only anabolic therapy currently approved for treatment of osteoporosis. The PTH receptor (PTH1R) is a G protein-coupled receptor that signals via multiple G proteins including G_sα. Mice expressing a constitutively active mutant PTH1R exhibited a dramatic increase in trabecular bone that was dependent upon expression of G_sα in the osteoblast lineage. Postnatal removal of G_sα in the osteoblast lineage (P-G_sα^OsxKO mice) yielded markedly reduced trabecular and cortical bone mass. Treatment with anabolic PTH(1–34) (80 μg/kg/day) for 4 weeks failed to increase trabecular bone volume or cortical thickness in male and female P-G_sα^OsxKO mice. Surprisingly, in both male and female mice, PTH administration significantly increased osteoblast numbers and bone formation rate in both control and P-G_sα^OsxKO mice. In mice that express a mutated PTH1R that activates adenylyl cyclase and protein kinase A (PKA) via G_sα but not phospholipase C via G_q/11 (D/D mice), PTH significantly enhanced bone formation, indicating that phospholipase C activation is not required for increased bone turnover in response to PTH. Therefore, although the anabolic effect of intermittent PTH treatment on trabecular bone volume is blunted by deletion of G_sα in osteoblasts, PTH can stimulate osteoblast differentiation and bone formation. Together these findings suggest that alternative signaling pathways beyond G_sα and G_q/11 act downstream of PTH on osteoblast differentiation.     

Disruption of Rhodopsin Dimerization with Synthetic Peptides Targeting an Interaction Interface

Although homo- and heterodimerizations of G protein-coupled receptors (GPCRs) are well documented, GPCR monomers are able to assemble in different ways, thus causing variations in the interactive interface between receptor monomers among different GPCRs. Moreover, the functional consequences of this phenomenon, which remain to be clarified, could be specific for different GPCRs. Synthetic peptides derived from transmembrane (TM) domains can interact with a full-length GPCR, blocking dimer formation and affecting its function. Here we used peptides corresponding to TM helices of bovine rhodopsin (Rho) to investigate the Rho dimer interface and functional consequences of its disruption. Incubation of Rho with TM1, TM2, TM4, and TM5 peptides in rod outer segment (ROS) membranes shifted the resulting detergent-solubilized protein migration through a gel filtration column toward smaller molecular masses with a reduced propensity for dimer formation in a cross-linking reaction. Binding of these TM peptides to Rho was characterized by both mass spectrometry and a label-free assay from which dissociation constants were calculated. A BRET (bioluminescence resonance energy transfer) assay revealed that the physical interaction between Rho molecules expressed in membranes of living cells was blocked by the same four TM peptides identified in our in vitro experiments. Although disruption of the Rho dimer/oligomer had no effect on the rates of G protein activation, binding of G_t to the activated receptor stabilized the dimer. However, TM peptide-induced disruption of dimer/oligomer decreased receptor stability, suggesting that Rho supramolecular organization could be essential for ROS stabilization and receptor trafficking.     

Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes

Arrestins are multi-functional proteins that regulate signaling and trafficking of the majority of G protein-coupled receptors (GPCRs), as well as sub-cellular localization and activity of many other signaling proteins. We report the first crystal structure of arrestin-3, solved at 3.0 Å resolution. Arrestin-3 is an elongated two-domain molecule with overall fold and key inter-domain interactions that hold the free protein in the basal conformation similar to the other subtypes. Arrestin-3 is the least selective member of the family, binding a wide variety of GPCRs with high affinity and demonstrating lower preference for active phosphorylated forms of the receptors. In contrast to the other three arrestins, part of the receptor-binding surface in the arrestin-3 C-domain does not form a contiguous β-sheet, which is consistent with increased flexibility. By swapping the corresponding elements between arrestin-2 and arrestin-3 we show that the presence of this loose structure is correlated with reduced arrestin selectivity for activated receptors, consistent with a conformational change in this β-sheet upon receptor binding.     

Identification of a platyhelminth neuropeptide receptor

We report the characterisation of the first neuropeptide receptor from the phylum Platyhelminthes, an early-diverging phylum which includes a number of important human and veterinary parasites. The G protein-coupled receptor (GPCR) was identified from the model flatworm Girardia tigrina (Tricladida: Dugesiidae) based on the presence of motifs widely conserved amongst GPCRs. In two different assays utilising heterologous expression in Chinese hamster ovary cells, the Girardia GPCR was most potently activated by neuropeptides from the FMRFamide-like peptide class. The most potent platyhelminth neuropeptide in both assays was GYIRFamide, a FMRFamide-like peptide known to be present in G. tigrina. There was no activation by neuropeptide Fs, another class of flatworm neuropeptides. Also active were FMRFamide-like peptides derived from other phyla but not known to be present in any platyhelminth. Most potent among these were nematode neuropeptides encoded by the Caenorhabditis elegans flp-1 gene which share a PNFLRFamide carboxy terminal motif. The ability of nematode peptides to stimulate a platyhelminth receptor demonstrates a degree of structural conservation between FMRFamide-like peptide receptors from these two distinct, distant phyla which contain parasitic worms.     

骨钙素的中枢调控作用及其生物学机制

骨钙素(OCN)能调节多种外周组织器官的生理结构与功能,也发挥重要的中枢调控作用,与个体的学习和记忆等高级认知功能密切相关。研究表明,OCN穿过血脑屏障进入大脑,并与神经元或神经胶质细胞膜上的G蛋白偶联受体(GPCR)家族成员GPR158和GPR37结合,激活或抑制细胞内相关信号通路,改变神经元或神经胶质细胞的生理活性。OCN在脑内的作用主要包括调节5-羟色胺、多巴胺、去甲肾上腺素和γ-氨基丁酸等神经递质合成与释放、增加脑源性神经营养因子表达、促进海马神经发生、增强海马神经元自噬及维持髓鞘稳态等。此外,OCN还能参与调控多种神经退行性疾病的病理生理学进程。在阿尔茨海默病(AD)中,OCN干预能够部分减少β-淀粉样蛋白(Aβ)沉积及Aβ诱发的细胞毒性等,改善学习和记忆能力缺陷;在帕金森氏病(PD)中,OCN干预能够部分抑制黑质和纹状体多巴胺能神经元丢失,增加酪氨酸羟化酶含量及降低神经炎症等,缓解运动功能障碍。本文通过解析GPR158和GPR37的结构与功能,分析OCN在脑内的作用及其生物学机制,探讨OCN对AD和PD等神经退行性疾病的影响,为进一步筛选促进脑健康的新型靶点提供依据。     

CC趋化因子偶联受体信号途径

Thechemokinesareafamilyofproinflammatorycytokinesthatactthroughcellsurfacereceptorstoregulatenumerousroutinephysiologicalandpathophysiologicalprocesses,includinghematopoiesis,T cellactivation ,angiogenesis,inflammatorydiseasesaswellasHIV 1infection[1,2 ].Thesesmallpeptidesaretypicallycomposedof 70 - 1 30aminoacidsandarecharacterizedbythepresenceoftwodisulphidebondsformedbetweenfourconservedcysteineresidues.Chemokinesareclassifiedintofoursubfamiliesaccordingtothepatternofconservedcysteinesinth…     

Detecting ligand interactions with G protein-coupled receptors in real-time on living cells

G protein-coupled receptors (GPCRs) are a large group of receptors of great biological and clinical relevance. Despite this, the tools for a detailed analysis of ligand–GPCR interactions are limited. The aim of this paper was to demonstrate how ligand binding to GPCRs can be followed in real-time on living cells. This was conducted using two model systems, the radiolabeled porcine peptide YY (pPYY) interacting with transfected human Y2 receptor (hY2R) and the bombesin antagonist RM26 binding to the naturally expressed gastrin-releasing peptide receptor (GRPR). By following the interaction over time, the affinity and kinetic properties such as association and dissociation rate were obtained. Additionally, data were analyzed using the Interaction Map method, which can evaluate a real-time binding curve and present the number of parallel interactions contributing to the curve. It was found that pPYY binds very slowly with an estimated time to equilibrium of approximately 12 h. This may be problematic in standard end-point assays where equilibrium is required. The RM26 binding showed signs of heterogeneity, observed as two parallel interactions with unique kinetic properties. In conclusion, measuring binding in real-time using living cells opens up for a better understanding of ligand interactions with GPCRs.